当前位置: 首页 > 期刊 > 《中国医药科学》 > 2012年第10期
编号:13179645
肥厚型梗阻性心肌病室间隔心肌消融术中国专家共识(5)
http://www.100md.com 2012年5月15日 《中国医药科学》 2012年第10期
     [38]Lakkis NM,Plana JC,Nagueh S,et al.Efficacy of nonsurgical septal reduction therapy in symptomatic patients with obstructive hypertrophic cardiomyopathy and provocable gradients.Am J Cardiol,2001,88:583-586.

    [39]Faber L,Ziemssen P, Seggewiss H. Targeting percutaneous transluminal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring.J Am Soc Echocardiogr,2000,13:1074-1079.

    [40]Veselka J,Zem ND,Tomaov D,et al.Alcohol septal ablation for obstructive hypertrophic cardiomyopathy:ultra-low dose of alcohol(1ml)is still effective.Heart Vessels,2009,24:27-30.

    [41]lacob M,Pinte F,Tintoiu I,et al.Microcoil embolisation for ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.Kardiol Pol,2004,61:350-355.

    [42]Durand E,Mousseaux E,Coste P,et al.Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy:early and 6 months follow-up.Eur Heart J,2008,29:348-355.

    [43]Buergler JM,Alam S,Spencer WJ,et al.Initial experience with alcohol septal ablation using a novel mag-netic navigation system.J Interv Cardiol,2007,20:559-663., 百拇医药
上一页1 2 3 4 5